Target intelligence / Profile preview

Pectate lyase Cry j 2 (Cry j 2)

Target
Cry j 2
Molecular classification
Enzyme, Pectate lyase, Polysaccharide lyase family 1, Plant allergen
01

Overview

Pectate lyase Cry j 2 is a 45 kDa protein and one of the two primary major allergens found in the pollen of the Japanese cedar (Cryptomeria japonica), which is the most significant cause of seasonal allergic rhinitis in Japan (UniProt: P19963). Biologically, the protein belongs to the polysaccharide lyase family 1 and functions as a pectate lyase, an enzyme that degrades pectin in the plant cell wall to facilitate pollen tube elongation during fertilization (PubMed: 22133374). In the human immune system, Cry j 2 serves as a potent trigger for Type I hypersensitivity reactions, where it cross-links allergen-specific IgE bound to FcεRI receptors on mast cells and basophils, leading to degranulation and the release of inflammatory mediators (WHO/IUIS). From a therapeutic perspective, Cry j 2 is a key target for allergen-specific immunotherapy (AIT), including sublingual (SLIT) and subcutaneous (SCIT) formulations like Cedartolen and Cedarcura, which aim to induce clinical tolerance by modulating the T-cell response (PubMed: 30129994). Clinical management involving this target relies on the measurement of Cry j 2-specific IgE for diagnosis and IgG4 as a biomarker for successful desensitization (PubMed: 25482324).

Other names
Major pollen allergen Cry j 2Cryptomeria japonica allergen 2Pectate lyase
02

Mechanism of action

Induction of immune tolerance via allergen-specific immunotherapy (AIT), characterized by a shift from Th2 to Th1 immune responses, the induction of regulatory T cells (Tregs), and the production of allergen-specific blocking IgG4 antibodies (PubMed: 30129994).

03

Biological functions

Pectin catabolic process (UniProt: P19963)Pollen tube growth (PubMed: 22133374)Induction of IgE-mediated immune response (WHO/IUIS)Degranulation of mast cells and basophils (PubMed: 25482324)
04

Disease associations

Allergic rhinitis (Japanese cedar pollinosis) (PubMed: 30129994)Asthma (WHO/IUIS)Allergic conjunctivitis (PubMed: 25482324)
05

Safety considerations

Systemic allergic reactions (PubMed: 30129994)AnaphylaxisLocal application site irritation (e.g., oral pruritus or swelling in SLIT)
06

Interacting drugs

Japanese cedar pollen extract (standardized)

2 more in the full profile.

07

Biomarkers

Cry j 2-specific IgE (PubMed: 25482324)Cry j 2-specific IgG4 (PubMed: 30129994)

Beyond the preview

Go deeper on Pectate lyase Cry j 2 (Cry j 2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pectate lyase Cry j 2 (Cry j 2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call